These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

988 related items for PubMed ID: 19384228

  • 1. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, Huber K, Geppert A.
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [Abstract] [Full Text] [Related]

  • 2. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B, Zeller M, Desgrès J, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Rioufol G, Beer JC, Makki H, Rochette L, Gambert P, Cottin Y.
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, Ikonomidis I, Ilias I, Armaganidis A, Orfanos SE, Dimopoulou I.
    Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
    [Abstract] [Full Text] [Related]

  • 5. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
    Geppert A, Dorninger A, Delle-Karth G, Zorn G, Heinz G, Huber K.
    Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
    [Abstract] [Full Text] [Related]

  • 6. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M.
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [Abstract] [Full Text] [Related]

  • 7. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR.
    Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).
    James SK, Lindahl B, Timmer JR, Ottervanger JP, Siegbahn A, Stridsberg M, Armstrong P, Califf R, Wallentin L, Simoons ML.
    Am J Cardiol; 2006 Jan 15; 97(2):167-72. PubMed ID: 16442356
    [Abstract] [Full Text] [Related]

  • 9. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.
    N Engl J Med; 2005 Feb 17; 352(7):666-75. PubMed ID: 15716560
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients].
    Li ZH, Xiao J, Li JZ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar 17; 23(3):179-82. PubMed ID: 21366951
    [Abstract] [Full Text] [Related]

  • 11. Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit.
    Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP.
    J Am Coll Cardiol; 2005 May 17; 45(10):1667-71. PubMed ID: 15893185
    [Abstract] [Full Text] [Related]

  • 12. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T.
    Am J Cardiol; 2006 Aug 15; 98(4):525-9. PubMed ID: 16893710
    [Abstract] [Full Text] [Related]

  • 13. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ, Zareba W, Bisognano JD.
    Am J Cardiol; 2007 Apr 15; 99(8):1143-5. PubMed ID: 17437744
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP, Ryan JE, van Gaal WJ, Lam QT, Sinnappu RN, Burrell LM, Savige J, Lim WK.
    Am J Cardiol; 2010 Sep 15; 106(6):865-72. PubMed ID: 20816130
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP, Wiviott SD, Sabatine MS, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DA.
    Am J Cardiol; 2007 Feb 01; 99(3):344-8. PubMed ID: 17261395
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D.
    Am J Cardiol; 2006 Jul 01; 98(1):111-5. PubMed ID: 16784932
    [Abstract] [Full Text] [Related]

  • 18. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction.
    Squire IB, O'Brien RJ, Demme B, Davies JE, Ng LL.
    Clin Sci (Lond); 2004 Sep 01; 107(3):309-16. PubMed ID: 15182235
    [Abstract] [Full Text] [Related]

  • 19. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.
    Am J Cardiol; 2007 Nov 15; 100(10):1571-6. PubMed ID: 17996522
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
    Am J Cardiol; 2007 Apr 15; 99(8):1051-4. PubMed ID: 17437726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.